June 9, 2008

From the News Wire: T1 Blood Test.

With the ADA Scientific Sessions going on the news wire will be buzzing.

Here is one one on technology for an early T1 detection.

Washington, June 9: A reliable, highly sensitive diagnostic blood test that identifies Type-1 diabetes patients in time for early intervention is around the corner thanks to the development of a new technology.




Other News:
Generex Biotechnology Commences Patient Dosing For Pivotal Phase III Trial Of Generex Oral-lyn For Type 1 Diabetes
Generex Biotechnology Corporation (NasdaqCM:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has commenced dosing of patients in a Phase III clinical trial of the Company's flagship product, Generex Oral-lynO, an oral insulin spray.


No comments :

Post a Comment